acyclovir and Communicable-Diseases--Emerging

acyclovir has been researched along with Communicable-Diseases--Emerging* in 2 studies

Other Studies

2 other study(ies) available for acyclovir and Communicable-Diseases--Emerging

ArticleYear
Anti-N-methyl-D-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges.
    Infection, 2017, Volume: 45, Issue:4

    Morbidity and mortality of Herpes simplex virus encephalitis (HSE) remain high. Relapses of neurological signs may occur after initial clinical improvement under acyclovir treatment.. We report here a case of post-HSE anti-N-methyl-d-aspartate receptor-mediated encephalitis in an adult and perform a systematic search on PubMed to identify other cases in adults.. We identified 11 previously published cases, to discuss diagnostic and therapeutic management. Symptoms in adults are often inappropriate behaviors, confusion and agitation. Diagnosis of anti-NMDA-R encephalitis after HSE is often delayed. Treatment consists in steroids, plasma exchange, and rituximab. Prognosis is often favorable.. Anti-NMDA-R antibodies should be searched in cerebrospinal fluid of patients with unexpected evolution of HSE. This emerging entity reopens the hot debate about steroids in HSE.

    Topics: Acyclovir; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiviral Agents; Communicable Diseases, Emerging; Encephalitis, Herpes Simplex; Female; France; Humans; Middle Aged; Recurrence

2017
Atypical West Nile virus infection in a child.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:9

    Topics: Acyclovir; Ceftriaxone; Child, Preschool; Communicable Diseases, Emerging; Drug Therapy, Combination; Follow-Up Studies; Glasgow Coma Scale; Humans; Infusions, Intravenous; Male; Ontario; Risk Assessment; Severity of Illness Index; Treatment Outcome; West Nile Fever; West Nile virus

2003